WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011012626) COMPOSITIONS COMPRISING THALIDOMIDE AND ARTEMISININ FOR THE TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/012626    International Application No.:    PCT/EP2010/060902
Publication Date: 03.02.2011 International Filing Date: 27.07.2010
IPC:
A61K 45/06 (2006.01)
Applicants: DAFRA PHARMA N.V. [BE/BE]; Slachthuisstraat 30/7 B-2300 Turnhout (BE) (For All Designated States Except US).
JANSEN, Frans, Herwig [BE/BE]; (BE) (For US Only)
Inventors: JANSEN, Frans, Herwig; (BE)
Agent: VAN KOOIJ, Adriaan; Sweelinckplein 1 NL-2517 GK Den Haag (NL)
Priority Data:
09167010.9 31.07.2009 EP
Title (EN) COMPOSITIONS COMPRISING THALIDOMIDE AND ARTEMISININ FOR THE TREATMENT OF CANCER
(FR) COMPOSITIONS COMPRENANT DE LA THALIDOMIDE ET DE L'ARTÉMISININE POUR LE TRAITEMENT DU CANCER
Abstract: front page image
(EN)The present invention relates to pharmaceutical compositions for the treatment of cancer and especially for the treatment of hematological malignancies such as multiple myeloma. Specifically, the present invention relates to pharmaceutical composition for the treatment of cancer comprising: thalidomide, or a derivative thereof, or salts or solvates thereof; one or more artemisinin compounds, or salts or solvates thereof; and one or more pharmaceutically acceptable carriers and/or excipients.
(FR)La présente invention concerne des compositions pharmaceutiques pour le traitement du cancer et en particulier pour le traitement des tumeurs malignes hématologiques telles que le myélome multiple. En particulier, la présente invention concerne des compositions pharmaceutiques pour le traitement du cancer, comprenant : de la thalidomide, ou un dérivé de celle-ci, ou des sels ou des solvates de ceux-ci; un ou plusieurs composés de l'artémisinine, ou des sels ou des solvates de ceux-ci; et un ou plusieurs vecteurs et/ou excipients pharmaceutiquement acceptables.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)